Universal Ibogaine (FRA:JC4) Receivables Turnover : 2.27 (As of Jan. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Universal Ibogaine's Revenue for the three months ended in Jan. 2025 was €0.25 Mil. Universal Ibogaine's average Accounts Receivable for the three months ended in Jan. 2025 was €0.11 Mil. Hence, Universal Ibogaine's Receivables Turnover for the three months ended in Jan. 2025 was 2.27.

Universal Ibogaine Receivables Turnover Historical Data

The historical data trend for Universal Ibogaine's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Receivables Turnover Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Jul24

Receivables Turnover

Get a 7-Day Free Trial

Universal Ibogaine Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Receivables Turnover	Get a 7-Day Free Trial															2.51	2.44	2.52	3.08	2.27

Competitive Comparison of Universal Ibogaine's Receivables Turnover

For the Biotechnology subindustry, Universal Ibogaine's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Universal Ibogaine Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Universal Ibogaine's Receivables Turnover for the fiscal year that ended in Jul. 2024 is calculated as

	Receivables Turnover (A: Jul. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jul. 2024 )	/ (	(Accounts Receivable (A: Jul. 2023 )	+	Accounts Receivable (A: Jul. 2024 ))	/	count )
=	1.567	/ (	(0	+	0)	/	1 )
=	1.567	/	0
=	N/A

Universal Ibogaine's Receivables Turnover for the quarter that ended in Jan. 2025 is calculated as

	Receivables Turnover (Q: Jan. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jan. 2025 )	/ (	(Accounts Receivable (Q: Oct. 2024 )	+	Accounts Receivable (Q: Jan. 2025 ))	/	count )
=	0.25	/ (	(0.093	+	0.127)	/	2 )
=	0.25	/	0.11
=	2.27

Universal Ibogaine (FRA:JC4) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Universal Ibogaine Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (FRA:JC4) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

IBOGF:USA IBO:Canada

Address

C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.

Universal Ibogaine Headlines

No Headlines